Close
Tirasemtiv not found effective for treatment of MND

Tirasemtiv not found effective for treatment of MND

Reading Time: 2 minutes In their official press release published on 21 November 2017, Cytokinetics Inc. announced that they will not be continuing work on tirasemtiv after disappointing results in the latest Phase 3 clinical trial. The trial, known under the acronym ‘VITALITY-ALS’, tested whether the drug has a beneficial effect on the breathing function and muscle strength of…